MedPath

Assessment of Endogenous Oxalate Synthesis

Not Applicable
Completed
Conditions
Kidney Stone
Obesity
Healthy
Registration Number
NCT05229952
Lead Sponsor
University of Alabama at Birmingham
Brief Summary

This study aims to determine the daily rate of endogenous synthesis of oxalate using carbon 13 oxalate isotope tracer technique and a low-oxalate controlled diet.

Detailed Description

Urinary oxalate excretion is derived from both dietary sources and endogenous synthesis. This study will use low-oxalate controlled diet and intravenous infusion of the isotope tracer carbon 13 oxalate, timed with blood and urine collections, to determine the daily rate of endogenous oxalate synthesis in non-stone forming volunteers and in subjects with calcium oxalate kidney stones. A DXA scan will be used to assess body composition.

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
23
Inclusion Criteria
  • Mentally competent adults, able to read and comprehend the consent form
  • Body Mass Index (BMI) between 18.5 and 50 kg/m2
  • Acceptable 24 hour urine collections (judged on screening)
  • good health as judged from a medical history, reported medications, and a complete blood metabolic profile
  • with or without history of calcium oxalate kidney stones
Exclusion Criteria
  • History of any hepatic, bowel, or endocrine disease or other condition that may influence the absorption, transport or urine excretion of ions
  • Abnormal urine chemistries or blood metabolic profiles
  • Poor 24 hour urine collections completed during screening, judged by 24 hour urine creatinine excretion (indicative of not collecting all urine in the 24 hour period)
  • Pregnancy, intention to become pregnant in the near future, or lactation
  • Aged lower than 18 or greater than 75 years
  • BMI lower than18.5 or greater than 50 kg/m2

Study & Design

Study Type
INTERVENTIONAL
Study Design
SEQUENTIAL
Primary Outcome Measures
NameTimeMethod
Endogenous Oxalate Synthesis Rateday 5

Daily oxalate synthesis rate (mg/day) determined by the 13c2-oxalate infusion method

Secondary Outcome Measures
NameTimeMethod
Urinary Creatinine Excretionday 3-4

24-hr urinary creatinine excretion (g/day) after equilibration on the low-oxalate controlled diet.

Urinary Oxalate Excretionday 3-4

24-hr urinary oxalate excretion (mg/day) after equilibration on the low-oxalate controlled diet, measured by ion chromatography coupled with mass spectrometry.

Trial Locations

Locations (1)

University of Alabama at Birmingham

🇺🇸

Birmingham, Alabama, United States

University of Alabama at Birmingham
🇺🇸Birmingham, Alabama, United States

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.